Company / Return on Assets (ROA)
BioNexus Gene Lab Corp Return on Assets (ROA) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-32.3%
FY2025
5-year range
-32.3% / 7.8%
FY2021-FY2025
Trend
-110.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 7 years, ranging from -32.3% in FY2025 to 10.8% in FY2020.
Based on SEC 10-K filings.
-32.3% in FY2025 with a 5-year CAGR of -43.1%.
Declined from -23.1% to -32.3% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -28.2pp
- 5-Year Change
- -43.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 110.6% year-over-year.
- Peak return on assets (roa) was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -32.3% | -110.6% |
| FY2024 | -15.3% | +33.6% |
| FY2023 | -23.1% | -466.6% |
| FY2022 | -4.1% | -151.8% |
| FY2021 | 7.8% | -27.4% |
| FY2020 | 10.8% | +154.0% |
| FY2019 | -20.0% | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026